SCA
ZOM

Snowden Capital Advisors’s Zomedica Corp. ZOM Stock Holding History

Snowden Capital Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-238,000
Closed -$47.6K – 1220
2023
Q2 		$47.6K Hold
238,000
– – ﹤0.01% 1156
2023
Q1 		$50.4K Hold
238,000
– – ﹤0.01% 1128
2022
Q4 		$38.8K Buy
238,000
+47,000
+25% +$9.63K ﹤0.01% 1113
2022
Q3 		$40K Hold
191,000
– – ﹤0.01% 1094
2022
Q2 		$42K Buy
191,000
+11,000
+6% +$2.8K ﹤0.01% 1099
2022
Q1 		$60K Buy
+180,000
New +$58.9K ﹤0.01% 1008

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Snowden Capital Advisors's ZOM Position: Q3 2023 in Review

Snowden Capital Advisors sold out of Zomedica Corp. (ZOM) in Q3 2023, closing a stake of 238,000 shares — an estimated $47.6K sold.

Snowden Capital Advisors first reported a position in ZOM in Q1 2022 and held it in 6 quarters. The position peaked at $60K in Q1 2022. 87 funds tracked by Wall St. Rank hold ZOM as of Q3 2023.

  • Snowden Capital Advisors reported no remaining Zomedica Corp. position as of Q3 2023 after selling out during the quarter.
  • Snowden Capital Advisors sold 238,000 Zomedica Corp. shares in Q3 2023, an estimated $47.6K.
  • Snowden Capital Advisors first reported a position in Zomedica Corp. in Q1 2022 and held it in 6 quarters.
  • Snowden Capital Advisors's Zomedica Corp. position peaked at $60K in Q1 2022.
  • 87 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2023.

Based on Snowden Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.